Enanta Pharmaceuticals | Salg

Sales Lave om Dato
AbbVie USD 14.3B 374M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Arrowhead Research USD 3.55M 12.55M 2023-12
AstraZeneca USD 12.02B 532M 2023-12
Biogen USD 2.29B 96.3M 2024-03
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Insmed USD 83.69M 4.62M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
J&J USD 21.38B 15M 2024-03
Ligand Pharmaceuticals USD 28.1M 4.77M 2023-12
Merck USD 14.63B 1.33B 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Enanta Pharmaceuticals Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.